NIH Hears Arguments Over Compulsory License For AIDS Drug
In December, Abbott Labs raised the wholesale price for a month's worth of the protease inhibitor Norvir, widely used in small doses to boost the potency of some AIDS combination-drug therapies, to $265 from $54.
The move caused an avalanche of protests from AIDS activists, who demanded a public meeting to consider...
Already a subscriber? Click here to login